N52.01 Insurance Policy Changes

ICD-10 N52.01 is officially defined as "Erectile dysfunction due to arterial insufficiency." code N52.01 is referenced in 10 tracked payer policy changes from Aetna and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code N52.01 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 12, 2026Medium impact
Nerve Grafting and Reconstruction: Selected Indications (CPB 0416, reviewed 2026-10-06)
Nerve allograft (Avance) is medically necessary for repair of short-to-medium sensory nerve gaps of 30 mm or less in the upper extremity, and CPT 64912 and 64913 are covered when those selection criteria are met. Nerve allograft for motor nerve repair, long gaps over 30 mm, large-diameter nerves, lower extremity reconstruction and all other indications not noted as medically necessary is experimental, investigational or unproven. Sural, cavernous and genitofemoral nerve grafts during radical retropubic prostatectomy, collagen and synthetic or xenograft nerve wraps and conduits for all indications, nerve wrapping for compression neuropathy, and vascularized nerve grafts for a nerve gap are also listed as not covered.
Aetna · Identified Oct 4, 2026Medium impact
Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation (CPB 0599, reviewed 2026-09-18)
Autologous skeletal myoblast transplantation, intra-coronary and intra-myocardial autologous bone marrow cell transplantation, and intra-arterial or intra-muscular autologous mononuclear bone marrow cell transplantation are considered experimental, investigational, or unproven because effectiveness has not been established. Autologous or allogeneic bone marrow-derived mesenchymal stem cell transplantation is likewise considered experimental, investigational, or unproven for conditions including acute myocardial infarction, diabetes, multiple sclerosis, knee osteoarthritis, spinal cord injury, rheumatoid arthritis, Crohn's disease, and peripheral nerve repair. CPT codes 0263T, 0264T, 0265T, 38240, and 38241 and HCPCS code C9782 are listed as not covered for the listed indications, and the ICD-10 codes for those indications are listed as not covered for these services.
Aetna · Identified Oct 4, 2026Medium impact
Nerve Grafting and Reconstruction: Selected Indications (CPB 0416, reviewed 2026-09-28)
Nerve allograft (Avance) is considered medically necessary for repair of short-to-medium sensory nerve gaps of 30 mm or less in the upper extremity. CPT 64912 and 64913 are covered when those selection criteria are met. Sural, cavernous and genitofemoral nerve grafts during radical retropubic prostatectomy, nerve allograft for motor nerve repair, long gaps over 30 mm, large-diameter nerves, lower extremity reconstruction, collagen conduits, and synthetic or xenograft nerve grafts and wraps for all indications are considered experimental, investigational or unproven. Cross-palm nerve grafting, intra-operative electrical stimulation, nerve wrapping for compression neuropathy, phrenic nerve reconstruction for diaphragmatic paralysis (other than prompt repair of acute phrenic nerve transection due to trauma or surgery), and vascularized nerve grafts for a nerve gap are also considered experimental, investigational or unproven.
Aetna · Identified Sep 29, 2026Medium impact
Abdominoplasty, Suction Lipectomy, and Ventral Hernia Repair (CPB 0211, reviewed 2026-08-18)
Aetna considers panniculectomy or apronectomy medically necessary when the panniculus hangs below the pubis on high-quality color photographs, the medical records show chronic intertrigo that recurs over 3 months or stays refractory to 3 months of appropriate therapy, and weights have been stable for the most recent 3 months; for bariatric patients, at least 12 months must have elapsed since the bariatric plateau. Repair of a true incisional or ventral hernia is considered medically necessary, and component separation is considered a medically necessary adjunct when a ventral hernia is larger than 10 cm in any direction, involves loss of domain, is 7 to 10 cm wide with a width to rectus abdominis width ratio of 2 or more, is complex with tissue loss, or follows prior failed repairs. Liposuction, lipectomy and excision of excessive skin are considered medically necessary for lipedema of the extremities after pain and disability persist despite 3 months or more of conservative management, and suction lipectomy of the trunk is considered medically necessary for lipedema when the specified pain, functional impairment and conservative-treatment criteria are met. Abdominoplasty, lipoabdominoplasty, suction lipectomy for indications other than lipedema and lymphedema, and panniculectomy that does not meet the criteria are considered cosmetic, repair of diastasis recti is considered not medically necessary, and several ventral hernia techniques, including enhanced-view totally extra-peritoneal repair, TAPPRA and peritoneal flap hernioplasty, are considered experimental, investigational or unproven.
Aetna · Identified Aug 17, 2026Medium impact
Nerve Grafting and Reconstruction: Selected Indications (CPB 0416, reviewed 2025-06-09)
Aetna's Clinical Policy Bulletin 0416 sets the medical necessity rules for nerve grafting and nerve reconstruction. Nerve allograft (Avance) is medically necessary for repair of short-to-medium sensory nerve gaps of 30 mm or less in the upper extremity, while nerve allograft for motor nerve repair, long gaps over 30 mm, large-diameter nerves, lower extremity reconstruction and all other indications not listed as medically necessary is experimental, investigational or unproven. Collagen conduits and synthetic or xenograft nerve grafts, including the AxoGen, Integra, NeuraGen, NeuraWrap, Neuromatrix and NeuroMend products, are experimental, investigational or unproven for all indications, and so are sural, cavernous and genitofemoral nerve grafts during radical retropubic prostatectomy, nerve wrapping for compression neuropathy, cross-palm nerve grafting for ulnar neuropathy, vascularized nerve grafts, intra-operative electrical stimulation of peripheral nerves in the upper extremity, and phrenic nerve reconstruction for diaphragmatic paralysis (this does not apply to prompt repair of acute phrenic nerve transection due to trauma or surgery).
Aetna · Identified Aug 14, 2026Medium impact
Pudendal Nerve Decompression (CPB 0805, reviewed 2025-11-20)
Aetna clinical policy bulletin 0805 considers pudendal nerve decompression experimental, investigational, or unproven for indications including chronic pelvic pain, interstitial cystitis, penile numbness and erectile dysfunction, persistent genital arousal disorder, pudendal neuralgia, and vulvodynia. The policy also considers pudendal nerve hydrodissection for chronic pelvic pain syndrome and urinary incontinence, and pudendal neurolysis for persistent genital arousal disorder and pudendal nerve entrapment syndrome, experimental, investigational, or unproven. The policy does not apply to pudendal nerve blocks used in obstetrics and other operative procedures.
Aetna · Identified Aug 13, 2026Medium impact
Erectile Dysfunction and Peyronie's Disease (CPB 0007, reviewed 2026-07-29)
Aetna considers the diagnosis and treatment of erectile dysfunction medically necessary under the criteria in its policy, including self-administered injectable medications, the external penile vacuum pump as a physician-prescribed durable medical equipment alternative to other therapies, and implantable penile prostheses when the documented criteria are met. Surgical correction of Peyronie's disease, such as plaque excisions, venous graft patching, tunica plication or the Nesbit tuck, is medically necessary for members who have the condition for 12 or more months with significant morbidity and have failed conservative medical treatment. Many other treatments, including extracorporeal shock wave therapy and testosterone injection for Peyronie's disease and stem cell therapy for erectile dysfunction, are considered experimental, investigational, or unproven.
Aetna · Identified Nov 2, 2026Low impact
Pudendal Nerve Decompression (CPB 0805, reviewed 2026-10-28)
Aetna's clinical policy bulletin 0805 on pudendal nerve decompression was reviewed on 10/28/2026. It treats pudendal nerve decompression, hydrodissection and neurolysis as experimental, investigational or unproven for chronic pelvic pain, pudendal neuralgia, interstitial cystitis, penile numbness and erectile dysfunction, persistent genital arousal disorder and vulvodynia, and it lists three related CPT codes as not covered for those indications. The source does not state an effective date for a change or describe a coverage change in this review.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA11.079e, Evaluation and Treatment of Erectile Dysfunction (ED)
Independence Blue Cross reissued MA11.079e on 01/21/2026 to communicate the Company's continuing position on ED evaluation and treatment. The policy adds CPT code 0864T (effective 01/02/2024) and now applies to New Jersey Medicare Advantage lines of business (effective 01/01/2024). No substantive coverage criteria changes were made in the most recent reissuance.
Independence Blue Cross · Identified Jun 19, 2026Low impact
11.11.01k, Evaluation and Treatment of Erectile Dysfunction (ED)
Independence Blue Cross reissued Policy 11.11.01k on 01/21/2026 with no substantive changes to erectile dysfunction evaluation and treatment coverage. The policy continues to cover medically necessary diagnostic procedures, vacuum constriction devices, penile prosthetic implants, and penile revascularization under specific clinical criteria. CPT code 0864T was previously added on 01/02/2024 as part of a CPT code update.

Watch N52.01

Get one email when a payer policy names N52.01, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code N52.01?

There are 10 tracked policy changes affecting code N52.01, including updates from Aetna, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code N52.01?

Payers that have issued tracked updates for code N52.01 include: Aetna, Independence Blue Cross.

How do I get notified when code N52.01 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code N52.01. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code N52.01?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Nerve Grafting and Reconstruction: Selected Indications (CPB 0416, reviewed 2026-10-06)

Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation (CPB 0599, reviewed 2026-09-18)

Nerve Grafting and Reconstruction: Selected Indications (CPB 0416, reviewed 2026-09-28)

Abdominoplasty, Suction Lipectomy, and Ventral Hernia Repair (CPB 0211, reviewed 2026-08-18)

Nerve Grafting and Reconstruction: Selected Indications (CPB 0416, reviewed 2025-06-09)

Pudendal Nerve Decompression (CPB 0805, reviewed 2025-11-20)

Erectile Dysfunction and Peyronie's Disease (CPB 0007, reviewed 2026-07-29)

Pudendal Nerve Decompression (CPB 0805, reviewed 2026-10-28)

MA11.079e, Evaluation and Treatment of Erectile Dysfunction (ED)

11.11.01k, Evaluation and Treatment of Erectile Dysfunction (ED)

What insurance policy changes affect code N52.01?

Which payers have updated policy for code N52.01?

How do I get notified when code N52.01 policy changes?

Why do payers change policies for code N52.01?